NIH Hides Away to Judge Diabetes Grant Apps
Published Date: 3/26/2025
Notice
Summary
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed virtual meeting on April 30, 2025, to review grant applications. This meeting affects researchers seeking funding for diabetes, digestive, and kidney disease projects. No public access is allowed to protect private and sensitive information, and the decisions could impact future research funding.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Closed Grant Review Affects Researchers
On April 30, 2025 from 1:00 p.m. to 2:30 p.m., the National Institute of Diabetes and Digestive and Kidney Diseases will hold a closed virtual meeting to review and evaluate grant applications (DEM RC2). The meeting is closed to the public to protect confidential trade secrets, patentable material, and personal information, and the panel's decisions could affect future research funding for diabetes, digestive, and kidney disease projects.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10814 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-04553 — Disaster Declarations Impacted by Hurricane Helene and Hurricane Milton
People affected by Hurricane Helene and Hurricane Milton get extra time to file disaster claims because of a funding pause from October to December 2024. The deadline for submitting paperwork is extended and the filing period is reopened to make sure no one misses out on help. This means more time and better chances to get the support they need!
Next: 2025-05036 — National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed virtual meeting on June 11-12, 2025, to review grant applications for fellowships in diabetes and metabolic diseases. This meeting affects researchers seeking funding and keeps sensitive info private. No money changes are announced, but the review helps decide who gets research support.